Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen

J Thromb Thrombolysis. 2018 Aug;46(2):211-218. doi: 10.1007/s11239-018-1678-2.

Abstract

Hypodysfibrinogenemia is the least frequently reported congenital fibrinogen disorder, characterized by both quantity and quality defects of fibrinogen. In this study, we investigated the molecular basis of hypodysfibrinogenemia in a Chinese family. Functional fibrinogen was measured by Clauss method, and the antigenic fibrinogen was measured by immunoturbidimetry assay. All the exons and exon-intron boundaries of fibrinogen genes (FGA, FGB and FGG) were analysed by direct DNA sequencing. To further evaluate its molecular and functional characterizations, fibrinogen was purified from the plasma of propositus, then SDS-PAGE, fibrin polymerization, clot lysis, and electron microscopy scanning were all performed. The propositus showed a slight decrease of immunologic fibrinogen (1.52 g/L) but dramatically reduced functional fibrinogen (0.3 g/L). DNA sequencing revealed a novel heterozygous CCTTTGATG deletion in the exon 8 of FGG, leading to the deletion of Ala289, Phe290, and Asp291 in fibrinogen γ-chain. The polymerization of the fibrinogen from the propositus was markedly impaired, with prolonged lag period and decreased final turbidity. The fibrinogen clottability showed a reduced fraction of participating clot formation. While the clot lysis showed normal. Scanning electron microscopy revealed that the fibers of the propositus were thicker than normal, with larger pores and curlier meshworks. We conclude that γAla289_Asp291del is responsible for the hypodysfibrinogenemia in this case.

Keywords: Amino acid deletion; Fibrin clot formation; Fibrin polymerization; Fibrinogen; Fibrinolysis; Hypodysfibrinogenemia.

MeSH terms

  • Afibrinogenemia / genetics*
  • Asian People
  • Family
  • Fibrinogen / analysis
  • Fibrinogen / genetics*
  • Fibrinogen / immunology
  • Humans
  • Polymerization
  • Sequence Analysis, DNA
  • Sequence Deletion*
  • Thrombosis

Substances

  • Fibrinogen

Supplementary concepts

  • Hypodysfibrinogenemia, Congenital